Skip to Content
The drug store chain-slash-health care juggernaut leapt three spots on this year's Fortune 500—and got a $62 billion revenue boost—due to its $69 billion acquisition of Aetna, the insurance giant, in 2018. Though investors haven’t entirely sweetened on the deal, CEO Larry Merlo pronounced the integration of the two companies “successful” in February; former Aetna CEO Mark Bertolini, meanwhile, resigned from the CVS board and said the integration was “far from over.” As a pharmacy retailer on the pandemic’s frontlines, CVS’s sales were brisk in the first quarter, but Merlo has warned about the “uncertainties” that surround the long-term performance of the company’s multifaceted business in a time of COVID-19.
Lists ranking CVS Health
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...READ MOREview in list
Global 500 - 2020This year's Global 500 generated $33.3 trillion in...READ MOREview in list
Fortune 500 - 2020This year's Fortune 500 marks the 66th running of ...READ MOREview in list